Photo from wikipedia
The International Extranodal Lymphoma Study Group (IELSG)‐37 is a prospective randomized trial assessing the role of consolidation mediastinal radiotherapy after immunochemotherapy to patients with newly diagnosed primary mediastinal large B‐cell… Click to show full abstract
The International Extranodal Lymphoma Study Group (IELSG)‐37 is a prospective randomized trial assessing the role of consolidation mediastinal radiotherapy after immunochemotherapy to patients with newly diagnosed primary mediastinal large B‐cell lymphoma (PMBCL). It is a positron emission tomography (PET) response‐guided study where patients obtaining a complete metabolic response on an end‐of‐therapy PET‐computed tomography (CT) scan evaluated by a central review are randomized to receive radiotherapy or no further treatment.
Journal Title: Hematological Oncology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!